Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding ATXS, Q4 2025
1 superinvestor reports holding Astria Therapeutics, Inc. on Form 13F, worth $11.4M in total. Weight is Astria Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q3 2025.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 0.2% | 873,400 | $11.4M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ATXS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2025
1 superinvestor holding at quarter end